Medifast, the parent company of OPTAVIA, reported its financial results for the first quarter of 2025. Revenue during the quarter was $115.7 million, a 33.8% decrease from the same period in 2024.

Medifast announced its financial results for the fourth quarter and full year 2024. Revenue during the fourth quarter was $119 million, with a revenue per active earning coach of $4,391.

Medifast announced its financial results for the fourth quarter and full year 2024. The parent company for direct selling organization OPTAVIA, Medifast reported fourth quarter revenue of $119 million.

Medifast announced the debut of OPTAVIA ASCEND, a new line that includes high-protein mini meals and daily nutrient packs. These new nutrition plans are designed to support those using GLP-1 medications and working to manage a healthy weight.

edifast, parent company of OPTAVIA, reported its third quarter 2024 financial results. Revenue for the quarter was $140.2 million, a 40.6% year-over-year decline. This decrease was primarily driven by lower OPTAVIA coach productivity and fewer active earning OPTAVIA coaches, which decreased by 36.3% from the same period last year.

Medifast, the parent company of direct selling organization OPTAVIA, announced its financial results for the second quarter of 2024, posting $168.6 million in revenue, a 43.1% decrease from the same period in 2023. The total number of active earning OPTAVIA Coaches decreased by 36.2% year over year to 33,900, with a 10.9% decline in their average revenue.

Medifast, the parent company of direct selling brand OPTAVIA, was recognized by US News & World Report as one of the nation’s Best Companies to Work For within the food and drink industry. This is the second consecutive year that Medifast has been included in this list.

Medifast, the parent company of direct selling organization OPTAVIA, announced the first phase of its national marketing campaign that will showcase the company’s GLP-1 medications and tailored weight loss and personalized coaching programs.

Medifast, the parent company of OPTAVIA, announced its first quarter 2024 financial results, posting $174.7 million in total revenue, a 49.9% decline when compared to the same quarter last year.

Medifast announced its fourth quarter and full year 2023 financial results, including fourth quarter revenue of $191 million and net income of $6 million. Earnings per diluted share during the quarter were $0.55. Revenue during the quarter was down 43.4%, which the company attributes to a decrease in the number of active earning OPTAVIA Coaches and the decline in productivity per active earning OPTAVIA Coach.

Medifast, the parent company of direct selling organization OPTAVIA, announced its entrance into the medically supported weight loss market with the launch of a collaboration with LifeMD, a virtual primary care provider. Medifast now plans to combine the expertise of board-certified clinicians and access to weight loss medications with OPTAVIA’s coach-guided approach to build a comprehensive health solution for the obesity epidemic.

Medifast, the parent company for direct selling organization OPTAVIA, released its financial results for the third quarter of 2023, reporting revenue of $235.9 million, a 39.6% decrease from the third quarter of 2022. Since the third quarter of 2022, the total number of active earning OPTAVIA coaches declined by 28.9% to 47,100, which the company views as the primary catalyst for recent revenue reduction.